Philips CPAP Lawsuit Update
Millions of recalled Philips DreamStation, CPAP, BiPAP and ventilator machines may release toxic foam particles and chemicals into the air pathway.
Millions of recalled Philips DreamStation, CPAP, BiPAP and ventilator machines may release toxic foam particles and chemicals into the air pathway.
The FDA recall is the latest in a string of problems with Philips breathing devices, which have resulted in thousands of lawsuits in recent years.
Both companies have accused each other of being responsible for problems with Philips CPAP machines, which have been linked to injuries and deaths.
Judge will hear evidence regarding a proposed Philips medical monitoring settlement, which provides funds to help detect future injuries among individuals who previously used recalled CPAP, BiPAP and ventilators.
The recalled OmniLab Advanced+ Ventilators may unexpectedly and intermittently reboot, putting users at risk of respiratory failure.
This is at least the third Philips BiPAP recall to impact these devices in recent years due to various problems, including risks of device failures and exposure to toxic chemicals
Recall shortly after Philips agreed to pay $1.1 billion to settle CPAP recall lawsuits filed over toxic sound abatement foam in other breathing machines
The agreement comes just days after a federal judge approved a similar settlement resolving Philips CPAP class action lawsuit claims.
Under a new schedule issued last week, it is likely that Philips CPAP injury lawsuit bellwether trials will not begin until late 2025, at the earliest.
Objections to the Philips CPAP settlement agreement will be addressed at a status conference scheduled for April 25.